- Open Access
The connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNA
Retrovirology volume 1, Article number: 33 (2004)
The primer tRNA for reverse transcription in HIV-1, tRNALys3, is selectively packaged into the virus during its assembly, and annealed to the viral genomic RNA. The ribonucleoprotein complex that is involved in the packaging and annealing of tRNALys into HIV-1 consists of Gag, GagPol, tRNALys, lysyl-tRNA synthetase (LysRS), and viral genomic RNA. Gag targets tRNALys for viral packaging through Gag's interaction with LysRS, a tRNALys-binding protein, while reverse transcriptase (RT) sequences within GagPol (the thumb domain) bind to tRNALys. The further annealing of tRNALys3 to viral RNA requires nucleocapsid (NC) sequences in Gag, but not the NC sequences GagPol. In this report, we further show that while the RT connection domain in GagPol is not required for tRNALys3 packaging into the virus, it is required for tRNALys3 annealing to the viral RNA genome.
During assembly of HIV-1, the major tRNALys isoacceptors in mammalian cells, tRNALys1,2 and tRNALys3, are selectively incorporated into the virus . tRNALys3 is the primer for initiating minus-strand cDNA synthesis, and its annealing to the 18 nucleotide primer binding site (PBS) region in the 5' part of the viral genome via the 3' 18 nucleotides in tRNALys3 complementary to the PBS, is a key step in viral replication . Other regions upstream and downstream of the PBS may also anneal with additional sequences in the tRNA [3, 4].
Both tRNALys3 and sites of annealing in viral RNA contain double stranded regions which may require denaturation for annealing to proceed efficiently. Nucleocapsid protein (NC) has been shown to facilitate tRNALys3 annealing both in vitro [5, 6] and in vivo , primarily through basic amino acids flanking the first zinc finger. While NC may destabilize viral RNA secondary structure, it has been demonstrated by several groups that nucleocapsid protein does not unwind the secondary structure of tRNA in vitro, and that the protein only has very subtle tertiary structural and helix destabilization effects on tRNALys3 alone [8–11].
Although processed nucleocapsid proteins have been shown to facilitate tRNALys3 annealing to genomic RNA in vitro, the annealing of primer tRNA onto the genomic RNA within HIV-1, murine leukemia virus, and avian retrovirus occurs independently of precursor protein processing [12–14]. However, while, tRNALys3 is annealed efficiently in protease-negative HIV-1 (about 80% that found in wild-type virions), optimal placement on the viral genome to achieve efficient initiation of reverse transcription requires exposure of the viral genome to mature nucleocapsid protein . In these protease-negative viruses, mutations in NC sequences within Gag inhibit tRNALys3 annealing, while mutations in NC sequences within GagPol do not, indicating the importance of Gag NC sequences in the annealing . In vitro, Gag has been reported to facilitate tRNALys3 annealing to viral RNA as efficiently as mature NC .
Nevertheless, we will present evidence in this report that GagPol still plays an important role in tRNALys3 annealing onto the viral RNA, independent of its role in the packaging of tRNALys3 into the virion. We present data herein indicating that the RT connection domain, while non-essential for tRNALys3 incorporation into virions, is required for tRNALys3 annealing to the viral RNA genome
The RT connection domain within GagPol is not required for tRNALys incorporation into virions, but is required for the annealing of tRNALys3 to the viral genome.
293T cells were transfected with protease-negative HIV-1 proviral DNA coding for either full length, protease-negative, GagPol (BH10.P-) or C-terminally deleted GagPol species. The different constructs are shown in Figure 1A, and are named according to the number of amino acids deleted from the C terminus of GagPol. Figure 1B shows Western blots of lysates of the viruses produced from the different transfections, probed with anti-CA, and shows that all forms of GagPol deletion mutants tested here are incorporated into the virion. Total viral RNA was isolated from these virions, and dot blots of this RNA were annealed with probes specific for either viral genomic RNA or tRNALys3, to determine the tRNALys3/genomic RNA in each viral variant. These results are shown graphically in Figure 1C, and support our previous results using COS7 cells , which indicate that tRNALys incorporation into virions is not dramatically affected until GagPol sequences including the thumb domain of RT are deleted (Δ581 and Δ715).
To measure the amount of tRNALys3 annealed in vivo to the viral RNA genome, total viral RNA was used as the source of primer/template in an in vitro reverse transcription reaction, using exogenous HIV-1 RT, dCTP, dTTP, α-32P-dGTP, and ddATP. This assay measures the amount of extendable tRNALys3 placed onto the viral genome. It is not known if all annealed tRNALys3 is extendable. Since the sequence of the first six dNTP's incorporated is CTGCTA, annealed primer tRNALys3 will be extended by 6 bases, and the extended tRNALys3 can be resolved and detected by one dimensional polyacrylamide gel electrophoresis (1D PAGE). These results are shown in Figure 2A, and presented graphically in Figure 2B. The left side of panel A shows that there is a linear increase in the reverse transcription signal over an almost 10 fold change in the amount of BH10.P- viral genomic RNA used in the reaction. The data in the right side of panel A indicate that C-terminal deletions of GagPol extending into the connection domain result in an 85% or greater decrease in the initiation of reverse transcription. Thus, the data in Figures 1 and 2 indicate that deletions extending into the RT connection domain do not significantly effect tRNALys incorporation, but do severely reduce the ability of tRNALys3 to be functionally annealed to the viral RNA genome.
Rescue of tRNALys3 annealing by GagPol
As shown in Figure 3, this annealing defect can be rescued by coexpression of full-length GagPol. 293T cells were transfected with plasmids coding for BH10P-, Δ467, or Δ486, or cotransfected with either Δ467 or Δ486 and a plasmid coding for full-length GagPol. Western blots of cell lysates probed with anti-RT or anti-β-actin are shown in panel A, while Western blots of lysates of virus produced from these cells and probed with anti-RT and anti-CA are shown in panel B. These data indicate that both full length GagPol and the truncated GagPol are incorporated into the viruses with similar efficiencies. As previously indicated in Figure 1C, the mutant virions incorporate approximately 80–85% of the tRNALys3 as BH10P-, but cotransfection of mutant DNA with DNA coding for GagPol gives a small increase in tRNALys3 packaged to over 90% of BH10P- (Figure 3C).
As shown in panels D and E, cotransfection with GagPol also moderately rescues tRNALys3 annealing in these mutant virions. Using equal amounts of total viral RNA as the source of primer/template in the in vitro RT assay, the ability of primer tRNALys3 to be extended 6 deoxynucleotides is shown in panel D, which shows the extended 6 base product resolved by 1D PAGE. Quantitation of these bands by phosphorimaging is presented graphically in panel E. As previously shown (Figure 2), tRNALys3 annealing is reduced to 12–15% that of BH10P-, but can be increased 4–5 fold by the additional presence of full-length GagPol. The fact that tRNALys3 annealing is only rescued by GagPol to approximately 50–55% the level of that obtained when only wild-type GagPol is present may reflect the fact that in these rescue experiments, the viral population contains approximately equal amounts of wild-type and mutant GagPol (Figure 3B).
Attempts were also made to rescue tRNALys3 annealing using mature RT fused to Vpr , but unlike full-length GagPol, the Vpr-RT was unable to rescue tRNALys3 annealing in the mutant virions (data not shown).
In vitro studies of the interaction between purified RT and tRNALys3 have indicated an interaction between the RT thumb domain and the tRNA [20–22]. In vivo studies also indicate an important role of the RT thumb domain in GagPol in tRNALys3 viral packaging. tRNALys3 incorporation into HIV-1 is not affected by deletion of the IN domain in GagPol, nor by further deletion of the RNaseH and connection domains in RT, but is severely inhibited by further deletion of the thumb domain as well . Thus tRNALys3 interacts with the RT thumb domain during incorporation into virions, and Gag nucleocapsid plays a role in promoting tRNALys3 annealing to viral RNA [5–7], presumably through a denaturation of annealing RNA sequences.
What then is the role the RT connection domain sequence in GagPol in facilitating tRNALys3 annealing? One possibility, suggested by in vitro studies, is that RT plays a direct role in tRNALys3 annealing. Early work indicated that the in vitro annealing of primer tRNATrp to AMV genomic RNA was promoted by the addition of AMV reverse transcriptase . In a later work, in which it was demonstrated that HIV-1 RT interacted with the D arm and TΨC loop of tRNALys3, HIV-1 RT was also shown facilitate the in vitro annealing of tRNALys3 to the PBS sequence . These in vitro works suggest that RT alone can directly promote tRNALys3 annealing to viral RNA. Whether the RT sequences in GagPol can function similarly in vivo is not known.
Alternatively, the RT connection domain may undergo interactions with Gag that may result in placing the tRNALys3 bound to the thumb domain in RT closer to either NC in Gag or to the genomic RNA that is bound to Gag NC. Recent work has indicated that that Pol sequences alone can bind to Gag p6 through the RT sequences in Pol . Pol protein alone is sufficient for obtaining both tRNALys incorporation into the virus and tRNALys3 annealing to the viral genome at levels approximately 35% those achieved using full-length GagPol. Thus, in addition to the interactions which probably occur between Gag and homologous sequences in the Gag part of GagPol, the interaction of RT sequences in GagPol with Gag p6 could place the RT-bound tRNALys3 closer to Gag NC sequences and viral RNA in the packaging complex. It remains to be determined which sequences within RT bind to Gag p6, but if it were those of the connection domain, this could explain how these sequences could promote tRNALys3 annealing through altering the configuration of GagPol.
Thus, two separate RT domains (thumb and connection) appear to be involved, respectively, in the viral incorporation of tRNALys3, and its annealing to HIV-1 RNA. One also finds two separate domains in Gag involved in these same processes. Evidence has been presented supporting the role of lysyl-tRNA synthetase (LysRS) in targeting tRNALys for viral incorporation, through a specific interaction of Gag capsid sequence with LysRS in a tRNALys/LysRS complex , while other evidence shows that Gag nucleocapsid sequence is involved in tRNALys3 annealing [6, 16, 17]. It is not known if LysRS plays any direct role in tRNALys3 annealing, and LysRS may be required to dissociate from tRNALys3 so as to free this tRNA for annealing to the viral RNA.
BH10 and BH10P- are protease-positive and protease-negative strains of HIV-1, respectively . All deletions mutants used here were derived from BH10.P-, and their construction has been previously described . hGagPolΔFSΔPR was a gift from Y. Huang and G. Nabel . It was constructed by deleting 5 thymidines in the frame shift site, and codes for GagPol. The codons have optimized for mammalian cell codon usage, which results in more efficient translation and protein production, and also makes nuclear export of these mRNAs Rev-independent through modification of the INS [27, 28]. hGag-PolΔFSΔPR contain an inactive protease due to an R42G mutation in the active site.
Production of wild type and mutant HIV-1 virus
Transfection of COS7 cells with wild type and proviral DNA was performed using the calcium phosphate method as previously described . Briefly, virus were isolated from the cell culture medium 63 hours post-transfection. The supernatant was first centrifuged in a Beckman GS-6R rotor at 3000 rpm for 30 minutes, and the virus were then pelleted from the resulting supernatant by centrifuging in a Beckman Ti45 rotor at 35,000 rpm for one hour. The viral pellet was then purified by centrifugation at 26,500 rpm for 1 hour through 15% sucrose onto a 65% sucrose cushion, using a Beckman SW41 rotor.
Viral particles were washed with 1X TNE and cellular or viral proteins were extracted with 1X RIPA buffer (10 mM Tris pH 7.4; 100 mM NaCI; 1% DOC; 0.1% SDS; 1%NP40; 2 mg/ml Aprotinin; 2 mg/ml Leupeptin; 1 mg/mlPepstatin A; 100 mg/ml PMSF). Western analysis was performed using 300 mg cellular protein or 10 μg viral protein, as determined by the Bradford assay . The cellular and viral lysates were resolved by SDS-1D PAGE, followed by blotting onto nitrocellulose membranes (Gelman Sciences). Detection of protein on Western blots utilized monoclonal antibodies or antisera specifically reactive with viral capsid (mouse antibody, Intracel), viral reverse transcriptase (rabbit antibody), or β-actin (mouse antibody, Sigma Aldrich). Western blots were analyzed by enhanced chemiluminescence (ECL kit, Amersham Life Sciences) using goat anti-mouse or donkey anti-rabbit (Amersham Life Sciences) as a secondary antibody, and quantitated using UN-SCAN-IT gelTM automated digitizing system. The sizes of the detected protein bands were estimated using pre-stained high molecular weight protein markers (GIBCO/BRL).
RNA Isolation and Analysis
Total viral RNA was extracted from viral pellets by the guanidinium isothiocyanate procedure , and dissolved in 5 mM Tris buffer, pH 7.5. To measure the incorporation of tRNALys3 into virions, hybridization to dot-blots of viral RNA was carried out with DNA probes complementary to tRNALys3  or to genomic RNA . To measure the amount of tRNALys3 annealed to genomic RNA, tRNALys3-primed initiation of reverse transcription was measured using total viral RNA as the source of primer tRNA/template in an in vitro HIV-1 reverse transcription reaction, as previously described . The sequence of the first 6 deoxynucleoside triphosphates incorporated is CTGCTA, and in the presence of dCTP, dGTP, dTTP, and ddATP, tRNALys3 is extended by 6 bases, and this product can be resolved by 1D PAGE, and quantitated by phosphorimaging, as previously described .
Jiang M, Mak J, Ladha A, Cohen E, Klein M, Rovinski B, Kleiman L: Identification of tRNAs incorporated into wild-type and mutant Human Immunodeficiency Virus Type 1. J Virol. 1993, 67: 3246-3253.
Mak J, Kleiman L: Primer tRNAs for reverse transcription. J Virol. 1997, 71: 8087-8095.
Beerens N, Groot F, Berkhout B: Inititation of HIV-1 reverse transcription is regulated by a primer activation signal. J Biol Chem. 2001, 276: 31247-31256. 10.1074/jbc.M102441200.
Isel C, Ehresmann C, Keith G, Ehresmann B, Marquet R: Initation of reverse transcription of HIV-1: Secondary structure of the HIV-1 RNA/tRNALys3 (Template/Primer) Complex. J Mol Biol. 1995, 247: 236-250. 10.1006/jmbi.1994.0136.
Dannull J, Surovoy A, Jung G, Moelling K: Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 1994, 13: 1525-1533.
De Rocquigny H, Gabus C, Vincent A, Fournie-Zaluski M-C, Roques B, Darlix J-L: Viral RNA annealing activites of Human Immunodeficiency Virus Type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci USA. 1992, 89: 6472-6476.
Huang Y, Khorchid A, Gabor J, Wang J, Li X, Darlix JL, Wainberg MA, Kleiman L: The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNALys3 genomic placement and initiation of reverse transcription in HIV-1. J Virol. 1998, 72: 3907-3915.
Khan R, Chang H-O, Kaluarachchi K, Gieddroc DP: Interaction of retroviral nucleocapsid proteins with transfer RNAPhe : a lead ribozyme and 1H NMR study. Nucl Acid Res. 1996, 24: 3568-3575. 10.1093/nar/24.18.3568.
Chan B, Weidemaier K, Yip W-T, Barbara PF, Musier-Forsyth K: Intra-tRNA Distance Measurements for Nucleocapsid Protein-Dependent tRNA Unwinding During Priming of HIV Reverse Transcription. Proc Natl Acad Sci USA. 1999, 96: 459-464. 10.1073/pnas.96.2.459.
Tisne C, Roques BP, Dardel F: Heteronuclear NMR studies of the interaction of tRNA(Lys)3 with HIV-1 nucleocapsid protein. J Mol Biol. 2001, 306: 443-454. 10.1006/jmbi.2000.4391.
Hargittai MRS, Mangla A, Gorelick RJ, Musier-Forsyth K: HIV-1 nucleocapsid protein zinc finger structures induce tRNALys3 tertiary structural changes, but are not critical for primer/template annealing. J Mol Biol. 2001, 312: 987-999. 10.1006/jmbi.2001.5021.
Huang Y, Wang J, Shalom A, Li Z, Khorchid A, Wainberg MA, Kleiman L: Primer tRNA Lys3 on the viral genome exists in unextended and two base- extended forms within mature Human Immunodeficiency Virus Type 1. J Virol. 1997, 71: 726-728.
Crawford S, Goff SP: A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J Virol. 1985, 53: 899-907.
Stewart L, Schatz G, Vogt VM: Properties of avian retrovirus particles defective in viral protease. J Virol. 1990, 64: 5076-5092.
Cen S, Khorchid A, Gabor J, Rong L, Wainberg MA, Kleiman L: The role of Pr55gag and NCp7 in tRNALys3 genomic placement and the initiation step of reverse transcription in HIV-1. J Virol. 2000, 74: 11344-11353. 10.1128/JVI.74.22.10796-10800.2000.
Cen S, Huang Y, Khorchid A, Darlix JL, Wainberg MA, Kleiman L: The role of Pr55gag in the annealing of tRNALys3 to Human Immunodeficiency Virus Type 1 genomic RNA. J Virol. 1999, 73: 4485-4488.
Feng YX, Campbell S, Harvin D, Ehresmann B, Ehresmann C, Rein A: The Human Immunodeficiency Virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J Virol. 1999, 73: 4251-4256.
Khorchid A, Javanbakht H, Parniak MA, Wainberg MA, Kleiman L: Sequences within Pr160gag-pol affecting the selective packaging of tRNALys into HIV-1. J Mol. 2000, 299: 17-26.
Wu X, Liu H, Xiao H, Conway JA, Hunter E, Kappes JC: Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO. 1997, 16: 5113-5122. 10.1093/emboj/16.16.5113.
Arts EJ, Miller JT, Ehresmann B, Le Grice SF: Mutating a region of HIV-1 reverse transcriptase implicated in tRNA(Lys-3) binding and the consequences for (-)-strand DNA synthesis. J Biol Chem. 1998, 273 (23): 14523-14532. 10.1074/jbc.273.23.14523.
Dufour E, Reinbolt J, Castroviejo M, Ehresmann B, Litvak S, Tarrago-Litvak L, Andreola ML: Cross-linking localization of a HIV-1 reverse transcriptase peptide involved in the binding of primer tRNALys3. J Mol Biol. 1999, 285 (4): 1339-1346. 10.1006/jmbi.1998.2430.
Mishima Y, Steitz JA: Site-Specific Crosslinking of 4-thiouridine-modified Human tRNALys3 to Reverse Transcriptase from Human Immunodeficiency Virus Type 1. EMBO J. 1995, 14: 2679-2687.
Araya A, Sarih L, Litvak S: Reverse transcriptase mediated binding of primer tRNA to the viral genome. Nucleic Acids Res. 1979, 6: 3831-3843.
Essink B, Das AT, Berkhout B: Structural requirements for the binding of tRNALys3 to reverse transcriptase of the Human Immunodeficiency Virus Type 1. J Biol Chem. 1995, 270: 23867-23874. 10.1074/jbc.270.40.23867.
Cen S, Niu M, Saadatmand J, Guo F, Huang Y, Nabel GJ, Kleiman L: Incorporation of pol into human immunodeficiency virus type 1 Gag virus- like particles occurs independently of the upstream Gag domain in Gag-pol. J Virol. 2004, 78: 1042-1049. 10.1128/JVI.78.2.1042-1049.2004.
Javanbakht H, Halwani R, Cen S, Saadatmand J, Musier-Forsyth K, Gottlinger HG, Kleiman L: The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. J Biol Chem. 2003, 278: 27644-27651. 10.1074/jbc.M301840200.
Huang Y, Kong W-P, Nabel GJ: Human immunodeficiency virus type I- specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J Virol. 2001, 75: 4947-4951. 10.1128/JVI.75.10.4947-4951.2001.
Qiu JT, Song R, Dettenhofer M, Tian C, August T, Felber BK, Pavlakis GN, Yu XF: Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J Virol. 1999, 73: 9145-9152.
Mak J, Jiang M, Wainberg MA, Hammarskjold M-L, Rekosh D, Kleiman L: Role of Pr160gag-pol in mediating the selective incorporation of tRNALys into Human Immunodeficiency Virus Type 1 particles. J Virol. 1994, 68: 2065-2072.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochemistry. 1976, 72: 248-254. 10.1006/abio.1976.9999.
Chomczynski P, Sacchi N: RNA isolation from cultured cells. Analytical Biochemistry. 1987, 162: 156-159. 10.1006/abio.1987.9999.
Huang Y, Mak J, Cao Q, Li Z, Wainberg MA, Kleiman L: Incorporation of excess wild type and mutant tRNALys3 into HIV-1. J Virol. 1994, 68: 7676-7683.
This work was supported by a grant from the Canadian Institutes for Health Research. We thank Y. Huang and G. Nabel for the gift of plasmid hGagPolΔFSΔPR.
SC carried out the molecular genetic studies, assisted by MJ. LK conceived of the study, and participated in its design and coordination. All authors read and approved the final manuscript.